Hypertension is a leading cause of cardiovascular disease and affects nearly one third of U.S. adults ([@b1-351-355],[@b2-351-355]). Because the risk for cardiovascular disease mortality increases as blood pressure increases, clinical recommendations for persons with stage 2 hypertension (systolic blood pressure \[SBP\] ≥160 mmHg or diastolic blood pressure \[DBP\] ≥100 mmHg) include a more extensive treatment and follow-up regime than for those with stage 1 hypertension (SBP 140--159 mmHg or DBP 90--99 mmHg) ([@b3-351-355]). Although racial/ethnic disparities in the prevalence of hypertension have been well documented ([@b4-351-355]); ethnic disparities in the awareness, treatment, and control within blood pressure stages have not. To examine racial/ethnic disparities in awareness, treatment, and control of high blood pressure by hypertension stages, CDC analyzed data from the National Health and Nutrition Examination Survey (NHANES) for the period 2003--2010. This report describes the results of that analysis, which indicated that the proportion of Mexican-Americans and blacks with stage 1 and stage 2 hypertension was greater than for whites.[\*](#fn1-351-355){ref-type="fn"} Among those with stage 1 hypertension, treatment with medication was significantly lower for Mexican-Americans compared with their non-Hispanic counterparts. Although treatment among persons with stage 2 hypertension did not differ by race/ethnicity, less than 60% of those with stage 2 hypertension were treated with medication. More efforts are needed to reduce barriers to accessing health care and low-cost medication, as well as increasing clinicians' hypertension treatment knowledge and adherence to clinical guidelines.

NHANES is an ongoing, stratified, multistage probability sample of the noninstitutionalized U.S. civilian population.[†](#fn2-351-355){ref-type="fn"} Interviews and detailed physical examinations are performed. To obtain statistically stable estimates within racial/ethnic groups, CDC analyzed data from four 2-year cycles (2003--2010). Examination response rates ranged from 75% to 77% during this period, resulting in a total of 22,992 adult (aged ≥18 years) participants. The analysis excluded women who were pregnant (n = 732), participants without a blood pressure measurement (n = 1,339), other Hispanics and persons of other race or of multiple race (n = 2,693), and persons without hypertension (n = 14,313). Some participants were excluded based on more than one criterion, yielding a final study sample of 6,632 participants. Hypertension was defined as an average SBP ≥140 mmHg or DBP ≥90 mmHg, based on the average of up to three blood pressure measurements,[§](#fn3-351-355){ref-type="fn"} or self-report of currently using blood pressure--lowering medication. Hypertension treatment was identified as the use of blood pressure--lowering medication and did not include lifestyle or dietary approaches. Hypertension stages were classified as stage 1 hypertension (SBP 140--159 mmHg or DBP 90--99 mmHg) and stage 2 hypertension (SBP ≥160 mmHg or DBP ≥100 mmHg) ([@b3-351-355]). Blood pressure control was defined as an SBP \<140 mmHg and DBP \<90 mmHg among those with hypertension. Hypertension awareness was determined based on whether a participant was ever told they had high blood pressure by a health-care provider. Health-care coverage was categorized into three groups: 1) Medicare, 2) private insurance, or 3) public insurance, which included Medicaid, a military health plan, or a state-sponsored plan.

All analyses were performed using statistical software to account for sampling weights and adjust variance estimates for the complex sampling design. A univariate chi-square test of independence was used to determine statistically significant (p\<0.05) differences across racial/ethnic groups. Because multiple NHANES cycles were combined, trends over time could not be examined, and prevalence estimates could not be age adjusted. Population counts were estimated using the Current Population Surveys provided from NHANES by averaging the population during the period coinciding with the four NHANES cycles.[¶](#fn4-351-355){ref-type="fn"}

Among those with hypertension, the proportion of persons who were aged \<65 years was greater for blacks (74.1%) and Mexican-Americans (71.9%) compared with whites (57.4%) ([Table 1](#t1-351-355){ref-type="table"}). Hypertension awareness, treatment, and control were lowest among Mexican-Americans (68.7%, 58.7%, and 35.5%, respectively) compared with whites (aware: 79.1%, treated: 71.2%, and controlled: 48.6%) and blacks (aware: 80.8%, treated: 71.9%, and controlled: 43.0%).

Among those with uncontrolled hypertension, awareness and treatment was greater for blacks (66.3% and 50.7%, respectively) compared with whites (aware: 59.4%, treated: 44.0%) and Mexican-Americans (aware: 51.4%, treated: 35.9%) ([Table 2](#t2-351-355){ref-type="table"}). Blacks with stage 1 hypertension had greater awareness (61.3%) and treatment (47.4%) compared with whites (awareness: 57.4%, treatment: 42.1%) and Mexican-Americans (awareness: 45.2%, treatment: 30.0%). Among those with stage 2 hypertension, blacks had greater awareness (77.6%) compared with whites (65.7%) and Mexican-Americans (66.0%); however, no difference was observed in hypertension treatment by race/ethnicity. Health-care coverage for those with uncontrolled hypertension was lowest for Mexican-Americans (59.3%) compared with blacks (77.7%) and whites (89.4%). However, among all persons with uncontrolled hypertension who were treated, the proportion who had health-care coverage was lower for Mexican-Americans (75.0%) compared with blacks (86.9%) and whites (94.4%). Awareness and treatment increased from stage 1 to stage 2 hypertension across all racial/ethnic groups.

Editorial Note
==============

The results presented in this report indicate that during 2003--2010, racial/ethnic disparities existed among U.S. adults with hypertension and within hypertension stages for age, awareness, treatment, and health-care coverage. Mexican-Americans and blacks with hypertension were significantly younger than whites. This might reflect earlier onset of hypertension among these racial/ethnic groups ([@b5-351-355]). Awareness and treatment was highest among blacks. This association is consistent with previous studies ([@b6-351-355],[@b7-351-355]) and might be a result of efforts to reduce the persistent high prevalence of hypertension among blacks. Although no significant difference was observed in hypertension treatment by race/ethnicity among those with stage 2 hypertension, treatment was low overall (50%--58%) in this high-risk group, for whom clinical guidelines recommend a two-drug combination ([@b3-351-355]). Data on the number or type of medication used by participants, including two-drug combinations, were not examined in this report. A greater proportion of blood pressure control among those treated for hypertension has been observed among Mexican-Americans (74%) and whites (75%) compared with blacks (62%) ([@b6-351-355]). To improve treatment and achieve the *Healthy People 2020* goal of blood pressure control in 61.2% of persons with hypertension ([@b8-351-355]) across all race/ethnic groups, targeted implementation of demonstrated, evidence-based community and clinical strategies is necessary ([@b1-351-355]).

In this study, the proportion of persons with health-care coverage was lowest among Mexican-Americans. Lack of health-care coverage has been associated with lower rates of hypertension awareness, treatment, and control ([@b9-351-355]). This might partially explain the observed lower treatment and awareness of hypertension among Mexican-Americans in this report.

What is already known on this topic?

It has been previously reported that one in three U.S. adults had high blood pressure during 2009--2010, and approximately half (53.3%) had their condition under control. The prevalence of high blood pressure differs by race/ethnicity, with the condition being more common among blacks (40.4%) compared with whites (27.4%) and Mexican-Americans (26.1%).

What is added by this report?

Based on data from the National Health and Nutrition Examination Survey for the period 2003--2010, high blood pressure control differed for whites (48.6%), blacks (43.0%), and Mexican-Americans (35.5%). Among those with hypertension, the proportion with stage 2 hypertension was greater for Mexican-Americans (19.2%) and blacks (17.7%) compared with whites (12.3%).

What are the implications for public health practice?

To reduce the prevalence of uncontrolled high blood pressure and the associated racial/ethnic disparities, efforts are needed to increase hypertension awareness and hypertension treatment and adherence, especially in the Mexican-American population. The Million Hearts initiative focuses on addressing these issues by presenting a multifactorial approach focusing on reducing cardiovascular risk factors, such as high blood pressure, and tailoring this approach to effectively reach different racial/ethnic populations.

The findings in this report are subject to at least five limitations. First, although the focus of the study was to investigate racial/ethnic disparities within blood pressure stages, CDC did not consider other racial/ethnic groups or respondents who were multiracial because sample sizes were too small for meaningful analysis. Similarly, the study could not consider other Hispanic subpopulations or Hispanics as a whole because of differences in NHANES sample design between the 2003--2006 and 2007--2010 cycles. Second, hypertension awareness and treatment as well as other covariates were self-reported and subject to recall bias. Third, hypertension treatment was based only on medication use, not accounting for participants who were using lifestyle or dietary approaches to reduce blood pressure, which might have resulted in an underestimation of proportion of adults with hypertension who received "treatment." Fourth, because of a limited number of participants with stage 2 hypertension within each cycle of NHANES, changes over time in the estimates were not evaluated. Finally, NHANES examination response rates ranged from 75% to 77%.

Racial/ethnic disparities exist in blood pressure, awareness, treatment, and control, with Mexican-Americans having a lower awareness and treatment of hypertension, as well as less health-care coverage, compared with blacks and whites. Multiple national efforts target improvements in high blood pressure prevention, treatment, and control ([@b3-351-355]). The Million Hearts initiative, co-led by CDC and the Centers for Medicare and Medicaid Services, is focusing efforts on preventing 1 million heart attacks and strokes by 2017, partially achieved by increasing blood pressure control for 10 million persons in the United States ([@b10-351-355]).[\*\*](#fn5-351-355){ref-type="fn"} Million Hearts is working to reduce cardiovascular disease risk factors through parallel efforts aimed at clinical settings and communities with a focus on the "ABCS" (i.e., appropriate aspirin use for those at risk, blood pressure control, cholesterol management, and smoking cessation). The initiative aims to improve prescription and patient adherence to appropriate medications for the ABCS, promote a heart-healthy lifestyle, and refine access to effective care, while bringing clinicians' attention to cardiovascular disease prevention, including appropriate drug regimens. Million Hearts also provides communities and clinical settings with resources and materials that are tailored for different racial/ethnic populations.

For this report, all persons of black or white race are non-Hispanic. Mexican-Americans might be of any race.

Additional information available at <http://www.cdc.gov/nchs/nhanes.htm>.

Additional information available at <http://www.cdc.gov/nchs/nhanes.htm>.

Additional information available at <http://www.cdc.gov/nchs/nhanes/response_rates_cps.htm>.

Additional information available at <http://millionhearts.hhs.gov/index.html>.

###### 

Prevalence of selected characteristics among adults aged ≥18 years with hypertension,[\*](#tfn2-351-355){ref-type="table-fn"} by race/ethnicity --- National Health and Nutrition Examination Survey, United States, 2003--2010[†](#tfn3-351-355){ref-type="table-fn"}

                                                                                                 Mexican-American   White, non-Hispanic   Black, non-Hispanic                                                                                  
  ---------------------------------------------------------------------------------------------- ------------------ --------------------- --------------------- ----- ------- ------ -------------- ------ ------- ------ -------------- ----- ---------
  **Sex**                                                                                                                                                                                                                                      
   Male                                                                                          505                52.4                  (49.4--55.4)          1.6   1,945   49.2   (47.6--50.7)   22.4   855     42.8   (40.4--45.2)   3.7   \<0.001
   Female                                                                                        557                47.6                  (44.6--50.6)          1.4   1,821   50.8   (49.3--52.4)   23.1   949     57.2   (54.8--59.6)   5.0   
  **Age group (yrs)**                                                                                                                                                                                                                          
   18--44                                                                                        121                25.0                  (20.7--29.4)          0.8   370     13.4   (11.6--15.2)   6.1    284     21.4   (19.2--23.6)   1.9   \<0.001
   45--64                                                                                        488                46.9                  (43.3--50.6)          1.4   1,207   44.0   (42.1--46.0)   20.0   869     52.7   (50.4--55.0)   4.6   
   ≥65                                                                                           453                28.0                  (25.3--30.7)          0.8   2,189   42.6   (40.4--44.8)   19.4   651     25.9   (23.2--28.7)   2.2   
  **Education (respondents aged ≥25 yrs)**                                                                                                                                                                                                     
   Less than high school diploma                                                                 677                57.7                  (52.7--62.8)          1.7   869     17.9   (15.2--20.6)   8.1    618     31.6   (28.5--34.7)   2.7   \<0.001
   High school diploma                                                                           170                19.3                  (16.2--22.4)          0.6   1,116   29.9   (27.8--32.0)   13.5   431     24.8   (22.4--27.2)   2.1   
   Some college                                                                                  141                15.2                  (11.4--19.0)          0.4   1,014   29.2   (27.2--31.2)   13.2   489     29.7   (27.5--31.9)   2.5   
   College degree or higher                                                                      58                 7.8                   (5.3--10.3)           0.2   737     23.1   (20.4--25.7)   10.4   235     13.9   (12.0--15.9)   1.2   
  **Poverty-to-income ratio**[¶](#tfn5-351-355){ref-type="table-fn"}                                                                                                                                                                           
   \<100%                                                                                        298                27.0                  (21.6--32.4)          0.8   403     7.2    (5.9-- 8.6)    3.3    336     18.5   (16.1--20.8)   1.6   \<0.001
   100%--299%                                                                                    474                43.1                  (38.6--47.6)          1.3   1,642   36.8   (34.2--39.4)   16.8   795     43.7   (40.9--46.4)   3.8   
   300%--499%                                                                                    126                13.9                  (10.6--17.2)          0.4   782     25.3   (23.0--27.6)   11.5   320     18.0   (15.7--20.4)   1.6   
   ≥500%                                                                                         164                16.0                  (11.9--20.1)          0.5   939     30.6   (27.6--33.6)   13.9   353     19.8   (17.6--22.0)   1.7   
  **Hypertension awareness**[\*\*](#tfn6-351-355){ref-type="table-fn"}                                                                                                                                                                         
   Aware                                                                                         768                68.7                  (64.9--72.4)          2.1   2,996   79.1   (77.3--80.9)   36.0   1,486   80.8   (78.2--83.4)   7.0   \<0.001
   Unaware                                                                                       294                31.3                  (27.6--35.1)          0.9   770     20.9   (19.1--22.7)   9.5    318     19.2   (16.6--21.8)   1.7   
  **Hypertension treatment**[††](#tfn7-351-355){ref-type="table-fn"}                                                                                                                                                                           
   Treated                                                                                       674                58.7                  (53.7--63.6)          1.8   2,725   71.2   (68.9--73.4)   32.4   1,335   71.9   (68.9--74.9)   6.2   \<0.001
   Untreated                                                                                     386                41.3                  (36.4--46.3)          1.2   1,035   28.8   (26.6--31.1)   13.1   469     28.1   (25.1--31.1)   2.4   
  **Hypertension controlled**[§§](#tfn8-351-355){ref-type="table-fn"}                                                                                                                                                                          
   Yes                                                                                           402                35.5                  (32.7--38.3)          1.1   1,795   48.6   (46.3--50.8)   22.1   786     43.0   (40.3--45.7)   3.7   \<0.001
   No                                                                                            660                64.5                  (61.7--67.3)          1.9   1,971   51.4   (49.2--53.7)   23.4   1,018   57.0   (54.3--59.7)   4.9   
  **Blood pressure stages**[¶¶](#tfn9-351-355){ref-type="table-fn"}                                                                                                                                                                            
   Normal                                                                                        127                12.0                  (10.1--14.0)          0.4   660     17.8   (16.5--19.1)   8.1    286     16.5   (14.8--18.1)   1.4   \<0.001
   Pre-hypertension                                                                              275                23.5                  (21.0--26.0)          0.7   1,135   30.8   (28.9--32.6)   14.0   500     26.5   (24.3--28.7)   2.3   
   Stage 1 hypertension                                                                          435                45.3                  (41.3--49.2)          1.4   1,429   39.2   (36.9--41.4)   17.8   699     39.3   (36.9--41.8)   3.4   
   Stage 2 hypertension                                                                          225                19.2                  (16.1--22.2)          0.6   542     12.3   (11.1--13.4)   5.6    319     17.7   (15.6--19.8)   1.5   
  **Health-care coverage**[\*\*\*](#tfn10-351-355){ref-type="table-fn"}                                                                                                                                                                        
   No                                                                                            302                35.0                  (31.1--38.9)          1.1   289     8.1    (6.8-- 9.3)    3.7    254     16.8   (14.5--19.0)   1.5   \<0.001
   Yes                                                                                           760                65.0                  (61.1--68.9)          2.0   3,477   91.9   (90.7--93.2)   41.8   1,550   83.2   (81.0--85.5)   7.2   
  **Health-care coverage type**[†††](#tfn11-351-355){ref-type="table-fn"}                                                                                                                                                                      
   Medicare                                                                                      204                19.6                  (14.9--24.3)          0.4   645     13.0   (11.5--14.5)   5.4    280     14.3   (12.7--16.0)   1.0   \<0.001
   Private                                                                                       344                53.3                  (47.3--59.4)          1.0   2,215   72.1   (69.9--74.3)   30.2   874     59.3   (56.5--62.2)   4.3   
   Public                                                                                        212                27.0                  (22.2--31.9)          0.5   617     14.9   (13.3--16.6)   6.2    396     26.4   (23.3--29.4)   1.9   
  **Routine place for health care**[§§§](#tfn12-351-355){ref-type="table-fn"}                                                                                                                                                                  
   Yes                                                                                           909                81.1                  (78.1--84.0)          2.4   3,592   94.8   (93.9--95.7)   43.1   1,721   94.7   (93.4--95.9)   8.2   \<0.001
   No                                                                                            153                18.9                  (16.0--21.9)          0.6   174     5.2    (4.3-- 6.1)    2.4    83      5.3    (4.1-- 6.6)    0.5   
  **No. of times received health care in past year**[¶¶¶](#tfn13-351-355){ref-type="table-fn"}                                                                                                                                                 
   0                                                                                             151                18.0                  (14.8--21.2)          0.5   190     5.5    (4.4-- 6.7)    2.5    132     8.5    (7.1--10.0)    0.7   \<0.001
   1                                                                                             139                14.8                  (11.7--17.8)          0.4   387     12.3   (10.9--13.6)   5.6    181     10.5   (9.0--12.1)    0.9   
   ≥2                                                                                            772                67.2                  (62.8--71.6)          2.0   3,187   82.2   (80.6--83.8)   37.4   1,487   80.9   (79.2--82.7)   7.0   

**Abbreviation:** CI = confidence interval.

Defined as systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥90 mmHg or currently using blood pressure--lowering medication.

Adult participants with no blood pressure measurement, self-reported race/ethnicity as "other/multiracial," and pregnant women were excluded.

Pearson chi-squared statistic, corrected for survey design.

Ratio of family income to poverty as defined by the U.S. Census Bureau. Information available at <http://www.census.gov/hhes/www/poverty/methods/definitions.html#ratio> of income to poverty.

Based on responses to the following questions, "Have you ever been told by a doctor or other health-care professional that you had hypertension, also called high blood pressure?" and "Were you told on two or more different visits that you had hypertension or high blood pressure?"

Based on whether the participant answered "yes" to both of the following questions: "Because of your high blood pressure, have you ever been told to take prescribed medicine?" and "Are you now taking prescribed medicine for high blood pressure?"

Based on blood pressure measurements for those with hypertension: controlled (SBP \<140 and DBP \<90) and uncontrolled (SBP ≥140 or DBP ≥90).

Classified as normal (SBP \<120 and DBP \<80), pre-hypertension (SBP 120--139 or DBP 80--89), stage 1 hypertension (SBP 140--159 or DBP 90--99), and stage 2 hypertension (SBP ≥160 or DBP ≥100).

Participants were asked, "Are you covered by health insurance or some other health-care plan?"

Health-care coverage types reported were Medicare, private insurance, and/or public health insurance (Medicaid, Children's Health Insurance Program \[CHIP\], state or other government sponsored health plan, or military health plan).

Based on response to the question, "Is there a place that you usually go when sick or need advice about health?"

Based on response to the question, "During the past 12 months, how many times have you seen a doctor or other health-care professional about your health, not including being hospitalized overnight?"

###### 

Prevalence of selected characteristics among adults aged ≥18 years with uncontrolled hypertension,[\*](#tfn15-351-355){ref-type="table-fn"} by stage of hypertension[†](#tfn16-351-355){ref-type="table-fn"} --- National Health and Nutrition Examination Survey, United States, 2003--2010

                                                                                                All uncontrolled hypertension                                                                                                      
  --------------------------------------------------------------------------------------------- ------------------------------- ------ -------------- ----- ------- ------ -------------- ------ ----- ------ -------------- ----- ---------
  **Sex**                                                                                                                                                                                                                          
   Male                                                                                         321                             53.9   (49.7--58.2)   1.0   1,009   49.9   (47.9--51.8)   11.7   523   48.0   (44.9--51.2)   2.4   0.139
   Female                                                                                       339                             46.1   (41.8--50.3)   0.9   962     50.1   (48.2--52.1)   11.7   495   52.0   (48.8--55.1)   2.6   
  **Age group (yrs)**                                                                                                                                                                                                              
  18--44                                                                                        97                              31.8   (27.1--36.5)   0.6   218     14.9   (12.5--17.3)   3.5    197   25.4   (22.3--28.4)   1.3   \<0.001
  45--64                                                                                        271                             39.6   (34.8--44.5)   0.8   587     42.0   (39.4--44.7)   9.8    477   50.4   (47.6--53.1)   2.5   
   ≥65                                                                                          292                             28.6   (24.8--32.3)   0.6   1,166   43.0   (40.3--45.8)   10.1   344   24.3   (21.0--27.5)   1.2   
  **Hypertension awareness**[¶](#tfn18-351-355){ref-type="table-fn"}                                                                                                                                                               
   Aware                                                                                        366                             51.4   (46.8--56.0)   1.0   1,201   59.4   (56.7--62.0)   13.9   700   66.3   (62.6--70.1)   3.3   \<0.001
   Unaware                                                                                      294                             48.6   (44.0--53.2)   0.9   770     40.6   (38.0--43.3)   9.5    318   33.7   (29.9--37.4)   1.7   
  **Hypertension treatment**[\*\*](#tfn19-351-355){ref-type="table-fn"}                                                                                                                                                            
   Treated                                                                                      274                             35.9   (30.1--41.7)   0.7   936     44.0   (41.3--46.7)   10.3   549   50.7   (46.6--54.8)   2.5   0.001
   Untreated                                                                                    386                             64.1   (58.3--69.9)   1.2   1,035   56.0   (53.3--58.7)   13.1   469   49.3   (45.2--53.4)   2.4   
  **Health-care coverage**[††](#tfn20-351-355){ref-type="table-fn"}                                                                                                                                                                
   Yes                                                                                          441                             59.3   (55.1--63.5)   1.2   1,783   89.4   (87.6--91.1)   20.9   825   77.7   (74.7--80.7)   3.8   \<0.001
   No                                                                                           219                             40.7   (36.5--44.9)   0.8   188     10.6   (8.9--12.4)    2.5    193   22.3   (19.3--25.3)   1.1   
  **Routine place for health care**[§§](#tfn21-351-355){ref-type="table-fn"}                                                                                                                                                       
   Yes                                                                                          524                             73.5   (69.1--77.9)   1.4   1,824   91.4   (89.7--93.2)   21.4   946   91.9   (89.7--94.1)   4.5   \<0.001
   No                                                                                           136                             26.5   (22.1--30.9)   0.5   147     8.6    (6.8--10.3)    2.0    72    8.1    (5.9--10.3)    0.4   
  **No. of times received health care in past year**[¶¶](#tfn22-351-355){ref-type="table-fn"}                                                                                                                                      
   0                                                                                            136                             25.5   (21.6--29.4)   0.5   175     10.0   (7.9--12.0)    2.3    125   14.2   (11.7--16.7)   0.7   \<0.001
   1                                                                                            109                             18.6   (14.5--22.7)   0.4   253     15.8   (14.1--17.6)   3.7    135   13.7   (11.1--16.3)   0.7   
   ≥2                                                                                           415                             55.9   (51.0--60.8)   1.1   1,542   74.2   (71.9--76.5)   17.4   757   72.1   (69.0--75.2)   3.6   

                                                                                                Stage 1 hypertension                                                                                                      
  --------------------------------------------------------------------------------------------- ---------------------- ------ -------------- ----- ------- ------ -------------- ------ ----- ------ -------------- ----- ---------
  **Sex**                                                                                                                                                                                                                 
   Male                                                                                         227                    57.1   (50.7--63.4)   0.8   779     52.9   (50.5--55.3)   9.4    381   50.4   (46.5--54.2)   1.7   0.212
   Female                                                                                       208                    42.9   (36.6--49.3)   0.6   650     47.1   (44.7--49.5)   8.4    318   49.6   (45.8--53.5)   1.7   
  **Age group (yrs)**                                                                                                                                                                                                     
  18--44                                                                                        81                     37.4   (31.3--43.5)   0.5   190     17.3   (14.5--20.2)   3.1    157   28.3   (24.5--32.2)   1.0   \<0.001
  45--64                                                                                        184                    38.7   (32.8--44.6)   0.5   478     45.0   (41.9--48.0)   8.0    333   50.8   (47.0--54.5)   1.7   
   ≥65                                                                                          170                    23.9   (19.7--28.1)   0.3   761     37.7   (35.0--40.4)   6.7    209   20.9   (16.8--25.0)   0.7   
  **Hypertension awareness**[¶](#tfn18-351-355){ref-type="table-fn"}                                                                                                                                                      
   Aware                                                                                        212                    45.2   (40.5--50.0)   0.6   839     57.4   (54.3--60.5)   10.2   450   61.3   (57.4--65.2)   2.1   \<0.001
   Unaware                                                                                      223                    54.8   (50.0--59.5)   0.7   590     42.6   (39.5--45.7)   7.6    249   38.7   (34.8--42.6)   1.3   
  **Hypertension treatment**[\*\*](#tfn19-351-355){ref-type="table-fn"}                                                                                                                                                   
   Treated                                                                                      153                    30.0   (24.6--35.4)   0.4   644     42.1   (39.1--45.2)   7.5    358   47.4   (43.5--51.4)   1.6   \<0.001
   Untreated                                                                                    282                    70.0   (64.6--75.4)   1.0   785     57.9   (54.8--60.9)   10.3   341   52.6   (48.6--56.5)   1.8   
  **Health-care coverage**[††](#tfn20-351-355){ref-type="table-fn"}                                                                                                                                                       
   Yes                                                                                          287                    58.4   (53.5--63.4)   0.8   1,279   88.9   (86.9--90.8)   15.8   576   79.4   (76.1--82.6)   2.7   \<0.001
   No                                                                                           148                    41.6   (36.6--46.5)   0.6   150     11.1   (9.2--13.1)    2.0    123   20.6   (17.4--23.9)   0.7   
  **Routine place for health care**[§§](#tfn21-351-355){ref-type="table-fn"}                                                                                                                                              
   Yes                                                                                          342                    72.7   (66.9--78.5)   1.0   1,314   91.0   (88.9--93.0)   16.2   650   92.1   (89.7--94.4)   3.1   \<0.001
   No                                                                                           93                     27.3   (21.5--33.1)   0.4   115     9.0    (7.0--11.1)    1.6    49    7.9    (5.6--10.3)    0.3   
  **No. of times received health care in past year**[¶¶](#tfn22-351-355){ref-type="table-fn"}                                                                                                                             
   0                                                                                            95                     26.9   (22.3--31.4)   0.4   128     10.0   (7.8--12.1)    1.8    80    13.7   (11.0--16.4)   0.5   \<0.001
   1                                                                                            75                     18.9   (14.2--23.6)   0.3   194     16.4   (14.3--18.4)   2.9    96    14.3   (11.3--17.3)   0.5   
   ≥2                                                                                           265                    54.2   (48.2--60.2)   0.7   1,106   73.6   (71.1--76.2)   13.1   522   72.0   (68.7--75.3)   2.5   

                                                                                                Stage 2 hypertension                                                                                                   
  --------------------------------------------------------------------------------------------- ---------------------- ------ -------------- ----- ----- ------ -------------- ----- ----- ------ -------------- ----- ---------
  **Sex**                                                                                                                                                                                                              
   Male                                                                                         94                     46.6   (39.9--53.2)   0.3   230   40.1   (36.3--44.0)   2.2   142   42.8   (37.0--48.5)   0.7   0.310
   Female                                                                                       131                    53.4   (46.8--60.1)   0.3   312   59.9   (56.0--63.7)   3.3   177   57.2   (51.5--63.0)   0.9   
  **Age group (yrs)**                                                                                                                                                                                                  
   18--44                                                                                       16                     18.7   (11.4--26.1)   0.1   28    7.1    (4.0--10.3)    0.4   40    18.7   (13.4--24.1)   0.3   \<0.001
   45--64                                                                                       87                     41.8   (34.6--49.0)   0.2   109   32.7   (28.4--37.0)   1.8   144   49.5   (44.1--54.9)   0.8   
   ≥65                                                                                          122                    39.5   (32.2--46.8)   0.2   405   60.2   (55.5--64.8)   3.4   135   31.8   (26.9--36.6)   0.5   
  **Hypertension awareness**[¶](#tfn18-351-355){ref-type="table-fn"}                                                                                                                                                   
   Aware                                                                                        154                    66.0   (55.7--76.2)   0.4   362   65.7   (61.6--69.7)   3.7   250   77.6   (71.8--83.4)   1.2   0.010
   Unaware                                                                                      71                     34.0   (23.8--44.3)   0.2   180   34.3   (30.3--38.4)   1.9   69    22.4   (16.6--28.2)   0.3   
  **Hypertension treatment**[\*\*](#tfn19-351-355){ref-type="table-fn"}                                                                                                                                                
   Treated                                                                                      121                    49.9   (39.6--60.3)   0.3   292   49.9   (44.9--54.9)   2.8   191   58.0   (51.0--65.0)   0.9   0.163
   Untreated                                                                                    104                    50.1   (39.7--60.4)   0.3   250   50.1   (45.1--55.1)   2.8   128   42.0   (35.0--49.0)   0.6   
  **Health-care coverage**[††](#tfn20-351-355){ref-type="table-fn"}                                                                                                                                                    
   Yes                                                                                          154                    61.3   (54.2--68.4)   0.4   504   90.9   (87.5--94.3)   5.1   249   74.1   (68.5--79.7)   1.1   \<0.001
   No                                                                                           71                     38.7   (31.6--45.8)   0.2   38    9.1    (5.7--12.5)    0.5   70    25.9   (20.3--31.5)   0.4   
  **Routine place for health care**[§§](#tfn21-351-355){ref-type="table-fn"}                                                                                                                                           
   Yes                                                                                          182                    75.4   (68.3--82.5)   0.4   510   92.8   (90.3--95.2)   5.2   296   91.6   (87.2--96.0)   1.4   \<0.001
   No                                                                                           43                     24.6   (17.5--31.7)   0.1   32    7.2    (4.8--9.7)     0.4   23    8.4    (4.0--12.8)    0.1   
  **No. of times received health care in past year**[¶¶](#tfn22-351-355){ref-type="table-fn"}                                                                                                                          
   0                                                                                            41                     22.3   (16.7--27.9)   0.1   47    10.0   (7.0--13.0)    0.6   45    15.3   (11.2--19.4)   0.2   0.005
   1                                                                                            34                     17.9   (10.8--24.9)   0.1   59    14.0   (9.6--18.3)    0.8   39    12.5   (8.8--16.1)    0.2   
   ≥2                                                                                           150                    59.8   (53.9--65.8)   0.3   436   76.0   (71.1--80.9)   4.2   235   72.3   (66.7--77.9)   1.1   

**Abbreviation:** CI = confidence interval.

Defined as an average systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥90 mmHg.

Stages of hypertension were stage 1 hypertension (SBP 140-159 or DBP 90-99) and stage 2 hypertension (SBP ≥160 or DBP ≥100).

Pearson chi-squared statistic, corrected for survey design.

Based on responses to the following questions, "Have you ever been told by a doctor or other health-care professional that you had hypertension, also called high blood pressure?" and "Were you told on two or more different visits that you had hypertension or high blood pressure?"

Based on whether the participant answered "yes" to both of the following questions: "Because of your high blood pressure, have you ever been told to take prescribed medicine?" and "Are you now taking prescribed medicine for high blood pressure?"

Participants were asked, "Are you covered by health insurance or some other health-care plan?"

Based on response to the question, "Is there a place that you usually go when sick or need advice about health?"

Based on response to the question, "During the past 12 months, how many times have you seen a doctor or other health-care professional about your health, not including being hospitalized overnight?"
